{
    "organizations": [],
    "uuid": "f715fcc1b4e59bc97324d17ceb6408317f9944d1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-glenmark-pharmaceuticals-de/brief-indias-glenmark-pharmaceuticals-dec-qtr-consol-profit-falls-78-pct-idUSFWN1PY0J4",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Glenmark Pharmaceuticals Dec-Qtr Consol Profit Falls 78 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* DEC QUARTER CONSOL PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 4.77 BILLION RUPEES LAST YEAR\n* CONSENSUS FORECAST FOR DEC QUARTER CONSOL PROFIT WAS 2.34 BILLION RUPEES\n* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 22.04 BILLION RUPEES VERSUS 25.35 BILLION RUPEES LAST YEAR\n* SAYS US BUSINESS DEGREW BY 40.21 PERCENT TO 73.59 BILLION RUPEES DURING Q3 Source text: bit.ly/2nOGwQS Further company coverage:\n ",
    "published": "2018-02-08T18:32:00.000+02:00",
    "crawled": "2018-02-09T16:54:55.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "dec",
        "quarter",
        "consol",
        "profit",
        "billion",
        "rupee",
        "versus",
        "profit",
        "billion",
        "rupee",
        "last",
        "year",
        "consensus",
        "forecast",
        "dec",
        "quarter",
        "consol",
        "profit",
        "billion",
        "rupee",
        "dec",
        "quarter",
        "consol",
        "revenue",
        "operation",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "last",
        "year",
        "say",
        "u",
        "business",
        "degrew",
        "percent",
        "billion",
        "rupee",
        "q3",
        "source",
        "text",
        "company",
        "coverage"
    ]
}